160 related articles for article (PubMed ID: 3606082)
1. Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin.
Fernández-Roblas R; Prieto S; Santamaría M; Ponte C; Soriano F
Antimicrob Agents Chemother; 1987 May; 31(5):821-2. PubMed ID: 3606082
[TBL] [Abstract][Full Text] [Related]
2. Infections caused by antibiotic-resistant Corynebacterium group D2.
Soriano F; Fernández-Roblas R
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):337-41. PubMed ID: 3137032
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility pattern of Corynebacterium striatum.
Martínez-Martínez L; Pascual A; Bernard K; Suárez AI
Antimicrob Agents Chemother; 1996 Nov; 40(11):2671-2. PubMed ID: 8913489
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of urinary isolates of Corynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acid.
Soriano F; Ponte C; Santamaría M; Torres A; Fernández-Roblas R
J Antimicrob Chemother; 1987 Sep; 20(3):349-55. PubMed ID: 3479417
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of catalase-positive coryneform organisms in clinical specimens: identification, clinical relevance, and antibiotic susceptibility.
Lagrou K; Verhaegen J; Janssens M; Wauters G; Verbist L
Diagn Microbiol Infect Dis; 1998 Jan; 30(1):7-15. PubMed ID: 9488824
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of 79 antimicrobial agents against Corynebacterium group D2.
García-Rodriguez JA; García Sánchez JE; Muñoz Bellido JL; Nebreda Mayoral T; García Sánchez E; García García I
Antimicrob Agents Chemother; 1991 Oct; 35(10):2140-3. PubMed ID: 1759839
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics.
Philippon A; Bimet F
Eur J Clin Microbiol Infect Dis; 1990 Dec; 9(12):892-5. PubMed ID: 2073900
[TBL] [Abstract][Full Text] [Related]
8. In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens.
Soriano F; Fernández-Roblas R; Calvo R; García-Calvo G; Pardeiro M; Bryskier A
J Antimicrob Chemother; 1998 Nov; 42(5):647-9. PubMed ID: 9848450
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance and antimicrobial susceptibility profile of the unknown human pathogen
Lefèvre CR; Pelletier R; Le Monnier A; Corvec S; Bille E; Potron A; Fihman V; Farfour E; Amara M; Degand N; Barraud O; Cattoir V; For The Gmc Study Group
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33734955
[No Abstract] [Full Text] [Related]
10. [Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
Marty N; Clave D; Cancet B; Henry-Ferry S; Didier J
Pathol Biol (Paris); 1988 May; 36(5):460-4. PubMed ID: 3136426
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of opportunistic species of the Corynebacterium and related coryneforms isolated from different clinical materials.
Chudnicka A; Kozioł-Montewka M
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):385-91. PubMed ID: 15315020
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of Corynebacterium group D2.
Santamaría M; Ponte C; Wilhelmi I; Soriano F
Antimicrob Agents Chemother; 1985 Dec; 28(6):845-6. PubMed ID: 4083869
[TBL] [Abstract][Full Text] [Related]
13. Activity of daptomycin and three comparator agents against non-diphtheriae Corynebacterium isolates of clinical interest.
Navas J; Salas C; Calvo J; Martínez-Martínez L
J Antimicrob Chemother; 2012 Mar; 67(3):776-8. PubMed ID: 22129591
[No Abstract] [Full Text] [Related]
14. In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2).
Muñoz-Bellido JL; Muñoz-Criado S; García-Rodríguez JA
J Antimicrob Chemother; 1996 May; 37(5):1005-9. PubMed ID: 8737151
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium.
Fernandez-Roblas R; Adames H; Martín-de-Hijas NZ; Almeida DG; Gadea I; Esteban J
Int J Antimicrob Agents; 2009 May; 33(5):453-5. PubMed ID: 19153032
[TBL] [Abstract][Full Text] [Related]
16. [Antibiotic susceptibility of Corynebacterium macginleyi strains causing conjunctivitis].
Espínola M; Somodevilla A; Domingo D; Alarcón T; López-Brea M
Rev Esp Quimioter; 2010 Dec; 23(4):196-200. PubMed ID: 21191558
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of corynebacteria isolated from ewe's mastitis.
Fernández EP; Vela AI; Las Heras A; Domínguez L; Fernández-Garayzábal JF; Moreno MA
Int J Antimicrob Agents; 2001 Dec; 18(6):571-4. PubMed ID: 11738347
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C
J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-Resistant Corynebacterium striatum Associated with Increased Use of Parenteral Antimicrobial Drugs.
Hahn WO; Werth BJ; Butler-Wu SM; Rakita RM
Emerg Infect Dis; 2016 Nov; 22(11):1908-14. PubMed ID: 27767926
[TBL] [Abstract][Full Text] [Related]
20. High frequency of macrolide resistance mechanisms in clinical isolates of Corynebacterium species.
Ortiz-Pérez A; Martín-de-Hijas NZ; Esteban J; Fernández-Natal MI; García-Cía JI; Fernández-Roblas R
Microb Drug Resist; 2010 Dec; 16(4):273-7. PubMed ID: 20624090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
